Hyundai Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hyundai Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Reyon Pharmaceutical Co Ltd
sales of 114.51 billion Korean Won [US$100.77 million]
Kukje Pharma Co Ltd
(117.64 billion Korean Won [US$103.52 million]
of which 89%
was Pharmaceutical), and
Theragen Etex Co Limited
(98.88 billion Korean Won [US$87.02 million]
During the year ended November of 2015, sales at
Hyundai Pharmaceutical Company Limited were 109.83 billion Korean Won (US$96.65 million).
a very small
increase of 1.8%
versus 2014, when the company's sales were 107.84 billion Korean Won.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Hyundai Pharmaceutical Company Limited had sales
of 111.86 billion Korean Won.
Sales of Pharmaceutical saw an increase
3.0% in 2015, from
90.27 billion Korean Won to 92.97 billion Korean Won.
Not all segments of Hyundai Pharmaceutical Company Limited experienced an increase in sales in 2015:
sales of Food fell 4.0% to 16.76 billion Korean Won.